A Therapeutic Insight of Niacin and Coenzyme Q10 Against Diabetic Encephalopathy in Rats. (Q46166368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

A Therapeutic Insight of Niacin and Coenzyme Q10 Against Diabetic Encephalopathy in Rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

Erratum to: A Therapeutic Insight of Niacin and Coenzyme Q10 against Diabetic Encephalopathy in Rats.

7 March 2020

main subject

ubidecarenone

0 references

diabetic encephalopathy

1 reference

1 reference

corrigendum / erratum

1 reference

10.1007/S12035-017-0488-4

DOI

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1007/S12035-017-0488-4

author

Tarek K. Motawi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Manal A. Hamed

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Hebatallah A Darwish

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Nagy S El-Rigal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Asmaa F Aboul Naser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

11 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

published in

Molecular Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1601-1611

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12035-016-9765-x

7 March 2020

exact match

0 references

cites work

Therapy insight: the impact of type 1 diabetes on brain development and function

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Central nervous system function in youth with type 1 diabetes 12 years after disease onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Cerebral glucose metabolism in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Psychoneuroimmune implications of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Immune-mediated CNS damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Coenzyme Q(10) , endothelial function, and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

The antioxidant response as a drug target in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Niacin in cardiovascular prevention: mechanisms, efficacy, and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Antiatherothrombotic effects of nicotinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Niaspan increases angiogenesis and improves functional recovery after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Effects of combined quercetin and coenzyme Q(10) treatment on oxidative stress in normal and diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Niaspan increases axonal remodeling after stroke in type 1 diabetes rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Induction of diabetes by Streptozotocin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

The vitamin nicotinamide: translating nutrition into clinical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Neuroprotective effects of donepezil against cholinergic depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Biochemical and neurotransmitters changes associated with tramadol in streptozotocin-induced diabetes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Diabetes alters the expression of partial vasoactivators in cerebral vascular disease susceptible regions of the diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Upregulation of ICAM-1 in diabetic rats after transient forebrain ischemia and reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Angiotensin-(1-7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-κB Pathways in HUVECs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Protective effects of coenzyme Q10 against angiotensin II-induced oxidative stress in human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Niacin inhibits vascular inflammation via downregulating nuclear transcription factor-κB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Hyperglycemia induces apoptosis in rat liver through the increase of hydroxyl radical: new insights into the insulin effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9765-X

Effect of aspartame on oxidative stress and monoamine neurotransmitter levels in lipopolysaccharide-treated mice.

21 January 2018

1 reference

12 December 2020

Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis

1 reference

12 December 2020

Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats

1 reference

12 December 2020

Recent progress in advanced glycation end products and diabetic complications

1 reference

12 December 2020

Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial

1 reference

12 December 2020

Caspases mediate tumor necrosis factor-alpha-induced neutrophil apoptosis and downregulation of reactive oxygen production

1 reference

12 December 2020

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

1 reference

12 December 2020

The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen

1 reference

12 December 2020

Is donepezil effective for treating Alzheimer's disease?

1 reference

12 December 2020

Cardiovascular risk factors and cognitive decline in middle-aged adults

1 reference

12 December 2020

Microsomal lipid peroxidation

1 reference

12 December 2020

Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease

1 reference

12 December 2020

Donepezil for dementia due to Alzheimer's disease

1 reference

12 December 2020

Type 2 diabetes and cognitive impairment

1 reference

12 December 2020

Diabetes-induced biochemical changes in central and peripheral catecholaminergic systems.

1 reference

12 December 2020

10.1007/S12035-016-9765-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26867655%20AND%20SRC:MED&resulttype=core&format=json

release_6x7yrv5xl5gxnbgsn2lweoxff4

7 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6x7yrv5xl5gxnbgsn2lweoxff4

24 November 2022

mapped directly with Wikidata item

1 reference